[Visceral leishmaniasis (kala-azar) as an opportunistic infection in immunosuppressed patients].
The occurrence of visceral leishmaniasis is rare in Switzerland. We discovered this disturbance in a patient while on immunosuppressive medication for mycosis fungoides. Untreated visceral leishmaniasis has a high mortality. It can be expected that more cases will be observed in patients treated with immunosuppressive drugs or in patients with the acquired immunodeficiency syndrome (AIDS).
Lüthy
R M
RM
Medizinische Abteilung, Spital Limmattal, Schlieren.
Kistler
H J
HJ
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000368:Aged; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000473:pathology; D008297:Male; D009182:Mycosis Fungoides / Q000150:complications* / Q000188:drug therapy; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy
D007166:Immunosuppressive Agents
Viszerale Leishmaniose (Kala-Azar) als opportunistischer Infekt bei immunsupprimiertem Patienten.